BRCA1 and breast carcinoma: Adamson et al., observed that the RAD52 p.S346X allele was associated with a reduced risk of breast cancer occurrence in carriers of pathogenic mutations in the BRCA2 gene and to a lesser extent in their BRCA1 counterparts [85].